Wed, May 12, 2010
[ Wed, May 12th 2010 ] - Market Wire
ENVIROTEK Becomes "SUFFER"
Tue, May 11, 2010
Mon, May 10, 2010
Sun, May 9, 2010
Sat, May 8, 2010
Fri, May 7, 2010
Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ] - Market Wire
Cordani Becomes CIGNA CEO
Thu, December 31, 2009
[ Thu, Dec 31st 2009 ] - Market Wire
Quit the Board
Wed, December 30, 2009
[ Wed, Dec 30th 2009 ] - Market Wire
Centric Grants Stock Options
Tue, December 29, 2009
Mon, December 28, 2009
Thu, December 24, 2009

King Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Health Care Conference


//health-fitness.news-articles.net/content/2010/ .. a-merrill-lynch-2010-health-care-conference.html
Published in Health and Fitness on Thursday, May 6th 2010 at 13:20 GMT by Market Wire   Print publication without navigation


BRISTOL, TN--(Marketwire - May 6, 2010) - King Pharmaceuticals, Inc. (NYSE: [ KG ]) today announced plans to provide a live webcast of its presentation scheduled for Thursday, May 13, 2010, at 1:00 p.m. ET at the Bank of America Merrill Lynch 2010 Health Care Conference at the Grand Hyatt Hotel in New York, New York. The webcast may include a discussion of the Company's marketed products, pipeline, strategy for growth, financial results and expectations, and other matters relating to its business.

Interested persons may access the live webcast via the internet on the King Pharmaceuticals website at the following link: [ http://www.kingpharm.com/Investors/Webcasts.cfm ]. A replay of the webcast may be accessed at this same link for a period of not less than 14 days after the live event.

About King Pharmaceuticals, Inc.
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly owned subsidiary, Alpharma, LLC, is also a leader in the development, registration, manufacture and marketing of pharmaceutical products for food producing animals.

Forward-Looking Statements
This release contains forward-looking statements which reflect management's current views of future events and operations, including, but not limited to, statements pertaining to the anticipated webcast of the Company's presentation on May 13, 2010. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. An important factor which may cause results to differ is whether King is able to webcast the presentation on May 13, 2010 as currently planned. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.

EXECUTIVE OFFICES
KING PHARMACEUTICALS, INC.
501 FIFTH STREET, BRISTOL, TENNESSEE 37620


Publication Contributing Sources